(Q35027938)

5 August 2017

title

Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors (English)

1 reference

5 August 2017

Grignaschi G

1

1 reference

5 August 2017

Invernizzi RW

2

1 reference

5 August 2017

Fanelli E

3

1 reference

5 August 2017

Fracasso C

4

1 reference

5 August 2017

Caccia S

5

1 reference

5 August 2017

Samanin R

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

British Journal of Pharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

124

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

1781-1787

1 reference

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

Functional correlates of serotonin 5-HT1 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Serotonin release estimated by transcortical dialysis in freely-moving rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: A Novel 5-HT2C/5-HT2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral Activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Role of serotonin receptors in the effect of sertraline on feeding behaviour.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Reduction of feeding behavior by the serotonin uptake inhibitor sertraline.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0702028

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0702028

1 reference

5 August 2017

1 reference

5 August 2017

1 reference